SYNBIAS PHARMA AG
6Patents
6Active
6Granted
43Portfolio score
Filing activity: Apr 29, 2011 → Jul 11, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10030043B2 | Method for the synthesis of clofarabine | Emerging Cross-Sectional Technologies | 1 | Active |
| US10308665B2 | Method for the synthesis of rapamycin derivatives | Chemistry; Metallurgy | 0 | Active |
| US10294208B2 | Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US9765083B2 | Method for the synthesis of irinotecan | Chemistry; Metallurgy | 0 | Active |
| US10526290B2 | Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US8846882B2 | Method of producing 4-demethoxydaunorubicin | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.